Misra A, Peethambaram A, Garg A. Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature. Medicine 2004;83:18–34.PubMedCrossrefGoogle Scholar
Ogden CL, Li Y, Freedman DS, Borrud LG, Flegal KM. Smoothed percentage body fat percentiles for U.S. children and adolescents, 1999–2004. Natl Health Stat Report 2011;43:1–7.Google Scholar
Adachi M, Asakura Y, Muroya K, Goto H, Kigasawa H. Abnormal adipose tissue distribution with unfavorable metabolic profile in five children following hematopoietic stem cell transplantation: a new etiology for acquired partial lipodystrophy. Clin Pediatr Endocrinol 2013;22:53–64.CrossrefPubMedGoogle Scholar
Levy J, Burnett ME, Magro CM. Lipophagic panniculitis of childhood: a case report and comprehensive review of the literature. Am J Dermatopathol 2017;39:217–24.Web of SciencePubMedCrossrefGoogle Scholar
Meacham LR, Sklar CA, Li S, Liu Q, Gimpel N, et al. Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study. Arch Intern Med 2009;169:1381–8.CrossrefWeb of SciencePubMedGoogle Scholar
Kimura L, Alvarez G, Li N, Pawlikowska-Haddal A, Moore TB, et al. Temporary resolution of insulin requirement in acquired partial lipodystrophy associated with chronic graft-versus-host disease. Pediatr Blood Cancer 2017;64.Web of SciencePubMedGoogle Scholar
Ceccarini G, Ferrari F, Santini F. Acquired partial lipodystrophy after bone marrow transplant during childhood: a novel syndrome to be added to the disease classification list. J Endocrinol Invest 2017;40:1273–4.PubMedCrossrefWeb of ScienceGoogle Scholar
Diker-Cohen T, Cochran E, Gorden P, Brown RJ. Partial and generalized lipodystrophy: comparison of baseline characteristics and response to metreleptin. J Clin Endocrinol Metab 2015;100:1802–10.CrossrefWeb of SciencePubMedGoogle Scholar
Brown RJ, Oral EA, Cochran E, Araujo-Vilar D, Savage DB, et al. Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy. Endocrine 2018;60:479–89.PubMedWeb of ScienceCrossrefGoogle Scholar
Corvillo F, Aparicio V, Lopez-Lera A, Garrido S, Araujo-Vilar D, et al. Autoantibodies against perilipin 1 as a cause of acquired generalized lipodystrophy. Front Immunol 2018;9:2142.CrossrefPubMedWeb of ScienceGoogle Scholar
Gokcebay DG, Azik F, Bayram C, Erdem AY, Fettah A, et al. Evaluation of endocrine and metabolic dysfunctions after hematopoietic stem cell transplantation in children: a study from Turkey. J Pediatr Endocrinol Metab 2017;30:683–91.PubMedWeb of ScienceCrossrefGoogle Scholar
Kim YS, Kim MS, Kim SI, Lim SK, Lee HY, et al. Post-transplantation diabetes is better controlled after conversion from prednisone to deflazacort: a prospective trial in renal transplants. Transpl Int 1997;10:197–201.CrossrefPubMedGoogle Scholar
Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941–6.PubMedCrossrefGoogle Scholar
About the article
Published Online: 2019-05-10
Published in Print: 2019-05-27
Author contributions: Mayumi Hosokawa, Hironori Shibata, Takahiro Hosokawa, Junichiro Irie, Hiroshi Ito and Tomonobu Hasegawa declare that they have no financial or personal relationships that could lead to a conflict of interest.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: None declared
Research involving human subjects: This research was performed in accordance with the tenets of the Declaration of Helsinki.